HTG Completes its Initial Public Offering

San Diego – May 20, 2015 – Cooley advised HTG Molecular Diagnostics, Inc. on its initial public offering. HTG is a commercial stage company that develops and markets a novel technology platform to facilitate the routine use of complex molecular profiling. The company trades on The NASDAQ Global Market under the symbol "HTGM."

The Cooley corporate securities team advising HTG included partners Wainwright Fishburn and Steve Przesmicki and associates Wade Andrews, Asa Henin, Matt Robbins and Sunny Chang.

Support for the offering was provided by partners Natasha Leskovsek and Wendy Goldstein and special counsel Phil Mitchell (health care and life sciences regulatory); partner Susan Cooper Philpot, senior counsel Bill Morrow and associate Todd Gluth (tax); and associate Megan Arthur (compensation and benefits).

About Cooley LLP

Cooley's lawyers solve legal issues for entrepreneurs, investors, financial institutions and established companies. Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, often where innovation meets the law.

Cooley has 850 lawyers across 12 offices in the United States, China and Europe.

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction, and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may have been generated with the assistance of artificial intelligence (AI) in accordance with our AI Principles, may be considered Attorney Advertising and is subject to our legal notices.